THEREFORE BE IT RESOLVED, that Post-Acute and Long-Term Care Medical Association (PALTmed), together with likeminded professional organizations, advocate for legislative and regulatory action ensuring patients cannot be denied appropriate admission to skilled nursing facilities based on blanket policies denying admission based solely on the diagnosis of opioid use disorder (OUD) or active medications for OUD (MOUD) use;
AND BE IT FURTHER RESOLVED, that Post-Acute and Long-Term Care Medical Association (PALTmed), advocates for and supports legislation and regulatory action for adequate reimbursement of skilled nursing facilities for the complexity of care and resources utilized for opioid use disorder (OUD) treatment;
AND BE IT FURTHER RESOLVED, that Post-Acute and Long-Term Care Medical Association (PALTmed), address barriers in the prescribing, dispensing, and administration of medications for opioid use disorder (MOUD) by skilled nursing facilities and long-term care associated pharmacies.
Note: Effective August 13, 2024, AMDA - The Society for Post-Acute and Long-Term Care Medicine is now Post-Acute and Long-Term Care Medical Association (PALTmed).